These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Using Bioluminescence Turn-On To Detect Cysteine in Vitro and in Vivo. Zhang M; Wang L; Zhao Y; Wang F; Wu J; Liang G Anal Chem; 2018 Apr; 90(8):4951-4954. PubMed ID: 29606000 [TBL] [Abstract][Full Text] [Related]
8. Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe. Zhou Y; Yin K; Dong H; Yang S; Li J; Luo J; Li Y; Yang R Anal Chem; 2021 Mar; 93(8):3726-3732. PubMed ID: 33601885 [TBL] [Abstract][Full Text] [Related]
9. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase. Kage KL; Richardson PL; Traphagen L; Severin J; Pereda-Lopez A; Lubben T; Davis-Taber R; Vos MH; Bartley D; Walter K; Harlan J; Solomon L; Warrior U; Holzman TF; Faltynek C; Surowy CS; Scott VE J Neurosci Methods; 2007 Mar; 161(1):47-54. PubMed ID: 17083980 [TBL] [Abstract][Full Text] [Related]
10. Intracellular Proteolytic Disassembly of Self-Quenched Near-Infrared Nanoparticles Turning Fluorescence on for Tumor-Targeted Imaging. Jiang J; Zhao Z; Hai Z; Wang H; Liang G Anal Chem; 2017 Sep; 89(18):9625-9628. PubMed ID: 28874046 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors. Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899 [TBL] [Abstract][Full Text] [Related]
12. A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening. Wang Y; Xu J; Uveges A; Ramarao MK; Rogers KE; Jones PG Anal Biochem; 2006 Jul; 354(1):35-42. PubMed ID: 16707086 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency. Tian G; Paschetto KA; Gharahdaghi F; Gordon E; Wilkins DE; Luo X; Scott CW Biochemistry; 2011 Aug; 50(32):6867-78. PubMed ID: 21728345 [TBL] [Abstract][Full Text] [Related]
14. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening. Ramarao MK; Murphy EA; Shen MW; Wang Y; Bushell KN; Huang N; Pan N; Williams C; Clark JD Anal Biochem; 2005 Aug; 343(1):143-51. PubMed ID: 16018870 [TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase inhibitors: a patent review (2009-2014). Lodola A; Castelli R; Mor M; Rivara S Expert Opin Ther Pat; 2015; 25(11):1247-66. PubMed ID: 26413912 [TBL] [Abstract][Full Text] [Related]
16. Amino-Acid-Encoded Supramolecular Nanostructures for Persistent Bioluminescence Imaging of Tumor. Huang Y; Yu Z; Peng J; Yu Q; Xu H; Yang M; Yuan S; Zhang Q; Yang Y; Gao J; Yuan Y Adv Healthc Mater; 2024 Jun; ():e2401244. PubMed ID: 38934340 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain. Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613 [TBL] [Abstract][Full Text] [Related]